Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes
American Journal of Physiology - Endocrinology and Metabolism, 07/16/2012
Broholm C et al. – Although leukemia–inhibitory factor (LIF) and LIF and its receptor (LIFR) proteins were increased in muscle tissue and myoblasts from diabetic patients, LIF signaling and LIF–stimulated cell proliferation were impaired in diabetic myoblasts, suggesting a novel mechanism by which muscle function is compromised in diabetes.



